E-diary firm Arrowhead Electronics is guaranteeing error-free, perfectly punctual projects. "Arrowhead has eliminated common causes of ePRO project failure such as requirements errors, study build delays, software customization errors, usability errors, non-compliance, obsolescence and data transmission errors," the firm notes. The Austin, Texas, firm's electronic patient-reported outcomes (ePRO) website is giving a bit more prominence to the short message systems (SMS) text alerts to patients.

Study Manager, a clinical trial management system heavily used in academia, is hosting a webinar on using its own system and the informed consent process. The Seattle, Washington, firm will include a case history. Here's more information.

The Obama pact with drug makers continues to be an embarrassment for members of the president's own party. Harry Reid, a top Democratic politician, has assured his constituents he's not bound by the pact to shield the industry from more severe penalties in exchange for $80 billion in voluntary, self-imposed pricing restraint. Here's an article.

Does Boehringer Ingelheim have a replacement to half-century-old warfarin? The privately held major pharma has presented data from an 18,000-patient trial of its anti-clotting drug, dabigatran. "These results are very good," said Fausto Pinto, director of the Lisbon Cardiovascular Institute and program chairman of the European Society of Cardiology. Here's a wire service story.

Andrew MacGarvey, the president of Quanticate, has republished his own Association for Clinical Data Management article on the importance of clinical data. MacGarvey writes: "More attention will be placed on mitigating the risk of bad data in our studies going forward, and this can only be a good thing, not just for the biometrics profession, but for development programs as a whole." Here's a ClinPage profile of the firm.

ERT appointed a new associate director of business development in Japan. Miki Stevens comes aboard from Parexel. Said Robert Brown, SVP, strategic marketing, planning and partnerships at ERT: “This new appointment continues our investment in the Japanese and wider Pacific Rim markets helping us to expand our direct sales reach and service the needs of our clients in the best possible way." Here's the release.

Have a news release? Send it to .(JavaScript must be enabled to view this email address)